Thrive Capital Management (Pennsylvania)’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.12M | Buy |
|
|||||
|
2025
Q2 | $3.41M | Buy |
|
|||||
|
2025
Q1 | $1.87M | Sell |
|
|||||
|
2024
Q4 | $2.6M | Buy |
|
|||||
|
2024
Q3 | $2.12M | Sell |
|
|||||
|
2024
Q2 | $2.04M | Buy |
|
|||||
|
2024
Q1 | $1.28M | Buy |
|
|||||
|
2023
Q4 | $226K | Sell |
|
|||||
|
2023
Q3 | $225K | Buy |
|
|||||
|
2023
Q2 | $225K | Sell |
|
|||||
|
2023
Q1 | $392K | Sell |
|
|||||
|
2022
Q4 | $756K | Sell |
|
|||||
|
2022
Q3 | $633K | Buy |
|
|||||
|
2022
Q2 | $361K | Buy |
|